Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Regional and disease-specific glycosaminoglycan composition and function in decellularized human lung extracellular matrix

Acta Biomaterialia(2023)10.1016/j.actbio.2023.06.043Source: DataRank Database

Regional and disease-specific glycosaminoglycan composition and function in decellularized human lung extracellular matrix is a research paper published in Acta Biomaterialia (2023). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 5.31)OA: hybridTopics (38)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Yuefan Song ORCID,Fuming Zhang ORCID,Loredana Asarian,Isaac Downs ORCID,Brad de Young

Live enrichment

PubMed:37433361 PMC:PMC10528722 OpenAlex:https://openalex.org/W4383698321

National Institutes of Health

Grant: RO1 HL12714401

National Heart Lung and Blood Institute

Grant: AI156573

National Heart Lung and Blood Institute

Grant: S10OD028523

National Science Foundation

Grant: DMR 1933525

Cystic Fibrosis Foundation

Grant: WEISS18P0

NHLBI NIH HHS

Grant: T32 HL076122

NIAID NIH HHS

Grant: R21 AI156573

NHLBI NIH HHS

Grant: R01 HL127144

Cystic Fibrosis Foundation Therapeutics Inc

FWCI

5.31

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.actbio.2023.06.043

HYBRIDhttps://doi.org/10.1016/j.actbio.2023.06.043

publisherhttps://doi.org/10.1016/j.actbio.2023.06.043

publisherhttps://api.elsevier.com/content/article/PII:S1742706123003756?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1742706123003756?httpAccept=text/plain

Fields of Study

Tissue Engineering and Regenerative MedicineProteoglycans and glycosaminoglycans researchElectrospun Nanofibers in Biomedical ApplicationsMedicineMaterials ScienceHumansGlycosaminoglycansLungChondroitin SulfatesPulmonary Disease, Chronic ObstructiveExtracellular MatrixDisaccharides

MeSH Terms

Chondroitin SulfatesDisaccharidesExtracellular MatrixGlycosaminoglycansHumansLungPulmonary Disease, Chronic Obstructive

Keywords

DecellularizationExtracellular matrixGlycosaminoglycanLungIdiopathic pulmonary fibrosisHeparan sulfatePathologyHyaluronic acidCOPDChemistryMedicineImmunologyCell biologyBiologyBiochemistryInternal medicineAnatomyExtracellular Matrix GelMatrix-associated Growth Factors

Sustainable Development Goals

SDG 0: Good health and well-being